Articles by Eileen Koutnik-Fotopoulos
Positive trial results and FDA approvals have changed the standard of care for NSCLC.
Researchers looked at unique features in epidemiology, risk factors, and biology of lung cancer in women.
A gap remains in understanding how lung cancer risk may be impacted by structural racism.
Diagnosing early-stage lung cancer with low-dose CT screening has shown significantly improved cure rates.
Researchers evaluated the impact of exercise and tai chi on quality life in patients with advanced lung cancer.
Researchers evaluated the safety, tolerability, and antitumor activity of Dato-DXd in treating NSCLC.
Removal of race correction in PFTs is a priority to address the inappropriate use of race within algorithms.
The effect of genomic alterations in NSCLC on brain metastases remains unclear.
Researchers examined the demographic and clinical outcomes in patients with KRAS-mutated tumors, using patients with NSCLC.
The optimal duration of ICI ± chemotherapy for patients with advanced non-small cell lung cancer remains unclear.
Potential disparities in lung cancer among other racial and ethnic groups in the United States have been poorly examined.
Researchers assessed the benefits and safety of biomarker-driven thromboprophylaxis among patients with lung and GI cancers.
A study assessed the clinical benefits and safety of thromboprophylaxis among patients with lung and GI cancers.
A study analyzed the efficacy and safety of radiotherapy in patients with SCLC with brain metastases.
Exposure to wildfire smoke has been shown to decrease the chances of lung cancer survival.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.